One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Inside This Issue
doi : 10.1016/S1936-8798(22)00706-3
Volume 15, Issue 8, 25 April 2022, Pages A11-A15
Dual Antiplatelet Therapy Discontinuation, Platelet Reactivity, and Adverse Outcomes After Successful Percutaneous Coronary Intervention
BjörnRedforsMD, PhDabc∗Ajay J.KirtaneMD, SMac∗MengdanLiuMSaDaniel R.MusikantowMDdBernhardWitzenbichlerMDeMichael J.RinaldiMDfD. ChristopherMetzgerMDgGioraWeiszMDacThomas D.StuckeyMDhBruce R.BrodieMDhOriBen-YehudaMDaciRoxanaMehranMDadGregg W.StoneMDad
Patterns and Outcomes of Dual Antiplatelet Therapy Discontinuation After Percutaneous Coronary Intervention
FrancescoFranchiMDFabianaRolliniMD
Radial Hemostasis Is Facilitated With a Potassium Ferrate Hemostatic Patch: The STAT2 Trial
Jordan G.SafirsteinMDaDavid M.TehraniMD, MSbJeffrey M.SchusslerMDcNicoleReidRN, MSN, RCISaKushMukerjeeMSaLarissaWeberRT, RCISaHenryLiuBSdSheaSkenderianEMTeMichaelSimeonEMTfTylerYanggArnold H.SetoMD, MPAgh
Hemostatic Patch for Accelerated Hemostasis After Transradial Procedures: A Step Further?
Olivier F.BertrandMD, PhDaZoltanRuzsaMD, PhDb
Femoral or Radial Approach in Treatment of Coronary Chronic Total Occlusion: A Randomized Clinical Trial
SevketGorguluMDaNihatKalayMDbTugrulNorgazMDaCuneytKocasMDcOmerGoktekinMDdEmmanouil S.BrilakisMD, PhDe
Femoral Versus Radial Artery Access for CTO PCIs: Is This the Final Round?
GiuseppeVadalà MDaAlfredo RuggeroGalassiMDb
Retrograde Chronic Total Occlusion Percutaneous Coronary Interventions: Predictors of Procedural Success From the ERCTO Registry
AungMyatMDaAlfredo R.GalassiMDbGerald S.WernerMD, PhDcKambisMashayekhiMDdAlexandreAvranMDeNicolasBoudouMDfMarkusMeyer-GessnerMDgNicolausReifartMD, PhDhMaciejLesiakMDiRobertoGarboMDjAlexanderBufeMDkJamesSprattMDlLeszekBryniarskiMD, PhDmEvald H.ChristiansenMD, PhDnGeorgiosSianosMD, PhDoJavierEscanedMD, PhDpCarlodi MarioMD, PhDqDavidHildick-SmithMDa
Retrograde Chronic Total Occlusion Percutaneous Coronary Interventions: Where We Stand and Where We Need to Go
DimitriKarmpaliotisMD, PhDAmiraliMasoumiMD
EROSION III: A Multicenter RCT of OCT-Guided Reperfusion in STEMI With Early Infarct Artery Patency
HaiboJiaMD, PhDab∗JiannanDaiMD, PhDab∗LupingHeMDab∗YishuoXuMDabYongfengShiMD, PhDcLeiZhaoMD, PhDcZhiqiSunMDdYinLiuMD, PhDeZiqianWengMDabXueFengMDabDiruiZhangMDabTaoChenMD, PhDabXilingZhangMDabLuluLiMScabYoushengXuMDabYanqingWuMD, PhDfYiningYangMD, PhDghChunmeiWangMD, PhDi…BoYuMD, PhDabâ€
Culprit Lesions Phenotypes in ST-Segment Elevation Acute Coronary Syndromes: A Call for Precision Medicine
DavideCapodannoMD, PhDClaudioLaudaniMD
Prophylactic Rivaroxaban Therapy for Left Ventricular Thrombus After Anterior ST-Segment Elevation Myocardial Infarction
ZhongfanZhangMDa∗DaoyuanSiMD, PhDa∗QianZhangMDaLinaJinMD, PhDbHaikuoZhengMD, PhDaMingQuMMcMiaoYuMMaZhenyaJiangMMaDelinLiMMaSoupingLiMMaPingYangMD, PhDaYuquanHeMD, PhDaWenqiZhangMD, PhDa
Preventing Left Ventricular Thrombus Formation: Another Reason to Use Very Low-Dose Rivaroxaban?
Matthew A.CavenderMD, MPHGrayson C.EubanksMD
Percutaneous Coronary Intervention Volume and Cardiac Surgery Availability Effect on Acute Coronary Syndrome-Related Cardiogenic Shock
SamerNoamanMBChBabcSaraVogrinMBBS, MBiostatbDiemDinhMBBS, PhDdJeffreyLefkovitsMBBSdAngela L.BrennanRNdChristopher M.ReidPhDdeAntonyWaltonMBBScDavidKayeMBBS, PhDcJason E.BloomMBBScDionStubMBBS, PhDacdYangYangMBBSfCraigFrenchMBBSfStephen J.DuffyMBBS, PhDcdNicholasCoxMBBSabWilliamChanMBBS, PhDabcVCOR Investigators
Percutaneous Coronary Intervention in Acute Coronary Syndrome and Cardiogenic Shock: Ensuring Access While Maintaining Quality
Alexander C.FanaroffMD, MHSabcAshwin S.NathanMD, MSabcd
The Need for Additional Phenotyping When Defining Cardiogenic Shock
CharanYerasiMDBrian C.CaseMDMohitPahujaMDItsikBen-DorMDRonWaksmanMD
Novel Telescope Anchoring Technique for Closure of Gigantic Coronary Fistulae Using 3-Dimensional Printing for Planning
WaelSumayaMDaDavidHorneMDbRobertChenMDcOsamaElkhateebMDa
A Novel Single-Cell, Double-Kissing Culotte Technique for Left Main Bifurcation Stenting
Pratik B.SandesaraMDNikolozShekiladzeMDWilliam J.NicholsonMDWissam A.JaberMD
Serial Change in Physiological Significance of Coronary Artery Disease With or Without Large Pericardial Effusion
TakayukiWarisawaMDabYukikoHashimotoMDacShunichiDoiMD, PhDdHisaoMatsudaMD, PhDaYoshihiro J.AkashiMD, PhDd
Mechanism of a Stuck Crown of the Orbital Atherectomy System and Successful Retrieval Procedure
HideakiAkaseMDTakayukiOkamuraMD, PhDTatsuhiroFujimuraMD, PhDYosukeMiyazakiMD, PhDTetsuyaMatsuyamaMDMasafumiYanoMD, PhD
Aortic Valve Insufficiency as a Late Complication After Impella Device Implantation
Jules R.OlsthoornMDaEveline A.C.GoossensMD, PhDbKayanLamMDaPim A.L.ToninoMD, PhDbJan-Mellevan DantzigMD, PhDb
“Level Crossroads�: A Venous Graft Compressing a Left Internal Mammary Graft Presenting as Myocardial Infarction
Brian O.BingenMD, PhDIbtihal AlAmriMDRoderick W.C.ScherptongMD, PhDJosé M.Montero CabezasMD
Novel Approach to Percutaneous Closure of an RCA Fistula via the Coronary Sinus
Adham M.KarimMDBenjamin J.StonerMDJoshua H.EasonDOJohn C.GurleyMDAndrew R.LeventhalMD, PhD
The Ratio Fallacy of Prosthesis–Patient Mismatch
Bart J.J.VeldersMDMichiel D.VriesendorpMDHoward C.HerrmannMDRobert J.M.KlautzMD, PhD
Reply: The Ratio Fallacy of Prosthesis–Patient Mismatch
HanbitParkMDSeung-JungParkMDDuk-WooParkMD
Short Duration of DAPT vs De-Escalation After Percutaneous Coronary Intervention: Only These 2 Options?
IñigoLozanoMD, PhDJose M.de la Torre HernandezMD, PhDArmandoPerez de PradoMD, PhDJose R.RumorosoMD, PhDBrunoGarcia del BlancoMD, PhD
Reply: Short Duration of DAPT vs De-Escalation After Percutaneous Coronary Intervention: Only These 2 Options?
ClaudioLaudaniMDAntonioGrecoMDGiovanniOcchipintiMDDominick J.AngiolilloMD, PhDDavideCapodannoMD, PhD
Predictors for Calcium Fracture With a Novel Cutting Balloon: An Optical Coherence Tomography Study
NaoyaKurataTakayukiIshiharaMDOsamuIidaMDTakuyaTsujimuraMDKazutoshiItoYosukeHataMDTakuToyoshimaMDNaokoHigashinoMDShoNakaoMDToshiakiManoMD, PhD
